News

Ovii Unveils Tropical Flavor for Women's Health Support

Ovii Unveils Tropical Flavor for Women's Health Support

Ovii Introduces New Tropical Flavor for Better Wellness

Ovii has recently launched a vibrant Tropical flavor to its innovative supplement designed for women's hormone and metabolic health. Co-founded by leading OB/GYN Dr. Thaïs Aliabadi and women's health advocate Mary Alice Haney, this supplement aims to elevate the daily health routines of women everywhere.

Transforming Health Routines

The Tropical flavor, bursting with delightful notes of pineapple, mango, and citrus, makes the experience of taking health supplements enjoyable. Ovii changes the narrative of supplements from a mundane task to a proactive part of daily life.

The Special Formula

What sets Ovii apart is its unique formulation featuring a 40:1 Inositol blend combined with patented Reducose®. This powerful combination is specifically crafted to provide dual-action support for optimal hormone balance and metabolic efficiency.

Comprehensive Health Benefits

With 16 clinically validated ingredients, Ovii supports women with increased energy, improved mood, and more regular menstrual cycles. Women can feel secure and reassured that they're getting clinically proven support without the hassle of multiple pills.

Targeting Key Health Issues

This innovative blend is scientifically shown to foster natural hormone balance and promote healthy menstrual cycles. With patented Reducose®, the body can process carbohydrates more effectively, addressing important post-meal blood sugar and insulin levels. Together, these ingredients not only target hormonal health but also aid those facing challenges with PCOS, PMS, and even menopause.

Empowering Women Through Science

Dr. Aliabadi emphasizes the importance of addressing not just hormone health but the overall well-being of women, stating that it is a vital aspect of their energy, mood, and fertility. Ovii seeks to turn the tide in women’s health by providing effective, science-backed solutions tailored for their unique biological needs.

Despite decades of neglect, women’s hormone and metabolic health is crucial for their everyday experiences—from energy levels to mood swings—making Ovii's purpose even more pressing.

Meeting Women Where They Are

Mary Alice Haney, co-founder of Ovii, highlights the supplement's commitment to meeting women at every stage of life. Whether a woman is in her twenties, navigating fertility issues, or dealing with menopause, Ovii serves as a reliable source of support.

A Movement for Change

More than just a product, Ovii represents a significant movement for women’s health. The SHE MD Podcast, co-hosted by Dr. Aliabadi and Haney, is dedicated to shedding light on often overlooked health topics, empowering women through education and awareness.

A New Standard in Women's Health

Ovii has garnered recognition as a recipient of the WholeFoods Magazine Natural Choice Award in the Women's Health category and has been acknowledged as a New Beauty 100 Winner for 2025. This recognition marks a new standard for doctor-developed solutions specifically for women.

Women can find Ovii available at selected retailers, including [Ovii.com](#), and on Amazon, where it will be featured with impressive discounts during major shopping events.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About Ovii

Ovii stands as a pioneering once-daily supplement that emphasizes hormone and metabolic health. Particularly beneficial for women facing PCOS, fertility concerns, or metabolic imbalances, Ovii was thoughtfully developed with the aid of expert OB-GYN collaboration, ensuring a holistic approach to wellness tailored for women.

About The Cofounders

Dr. Thaïs Aliabadi and Mary Alice Haney, the dynamic co-founders of Ovii, aim to empower women by facilitating enlightening discussions through their SHE MD Podcast. Dr. Aliabadi is a highly regarded board-certified OB/GYN, while Haney is a seasoned media professional championing women's health awareness and empowerment.

Frequently Asked Questions

What is Ovii?

Ovii is a once-daily supplement designed to support women's hormone and metabolic health.

What are the key ingredients in Ovii?

Ovii includes a unique formulation of a 40:1 Inositol blend and patented Reducose® to promote hormonal balance and metabolic efficiency.

Who can benefit from using Ovii?

Women experiencing challenges related to hormonal health, including PCOS, PMS, or menopause, can greatly benefit from Ovii.

How does Ovii work?

Ovii's formulation targets hormones and metabolism to support energy, mood, and menstrual regularity through scientifically backed ingredients.

Where can I purchase Ovii?

Ovii is available at Ovii.com and Amazon, often with special promotional pricing.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles